UVA-1 cold light treatment of SLE: A double blind, placebo controlled crossover trial

Annals of the Rheumatic Diseases

Volumn 60, Issue 2, 2001, Pages 112-115

  Polderman, M C A ^a   Huizinga, T W J ^a   Le Cessie, S ^a   Pavel, S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PLACEBO;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0035138349     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.2.112     Document Type: Article

References (16)

1. Interleukin-10 production by cultured human keratinocytes: Regulation by ultraviolet B and A1 radiation
2. Ultraviolet A1 radiation-induced immunomodulation: High-dose UVA-1 therapy of atopic dermatitis
3. High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial
4. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice
5. Light as exciting agent in lupus erythematosus and other dermatoses
6. Effect of light on skin diseases
7. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients
8. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings
9. Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black x New Zealand white) F1 hybrid mice
10. Prospects for UV-A1 therapy as a treatment modality in cutaneous and systemic LE
11. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus
12. UV-A-1-Therapie bei subakut kutanem Lupus erythematodes
13. Derivation of the SLEDAI. A disease activity index for lupus patients
14. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
15. The RAND-36 Short-form Health Status Survey: I. Conceptual framework and item selection
16. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus